drugset / Trial / NCT00045318
Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of exatecan mesylate in treating patients who have advanced solid tumors and kidney dysfunction.
Timeline
- Start
- 2002-05
- Primary completion
- —
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | exatecan | Small molecule | — | Intravenous |